fbpx Skip to main content

Member's Profile

Urovant Sciences, Inc.

5281 California Ave Ste 100
Irvine,   California
United States
Membership Info
Membership Type: Industry
Membership Since: 2018
Need to make an update to your Member Profile or have a question? Contact us here: [email protected]
About Urovant Sciences, Inc.
Biotech Company
Urovant Sciences, Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for urologic conditions. Urovant’s lead product candidate, vibegron, is a potent and selective 3-adrenergic agonist being developed for an oral, once-daily treatment for overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency. Urovant has licensed global rights, excluding Japan and certain Asian territories, for the development and commercialization of vibegron. Urovant intends to develop treatments for additional urologic diseases.
Related News
No related news posted by this Member